UniProt ID | REN3A_HUMAN | |
---|---|---|
UniProt AC | Q9H1J1 | |
Protein Name | Regulator of nonsense transcripts 3A | |
Gene Name | UPF3A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 476 | |
Subcellular Localization | Nucleus. Cytoplasm. Shuttling between the nucleus and the cytoplasm. | |
Protein Description | Involved in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons by associating with the nuclear exon junction complex (EJC) and serving as link between the EJC core and NMD machinery. Recruits UPF2 at the cytoplasmic side of the nuclear envelope and the subsequent formation of an UPF1-UPF2-UPF3 surveillance complex (including UPF1 bound to release factors at the stalled ribosome) is believed to activate NMD. However, UPF3A is shown to be only marginally active in NMD as compared to UPF3B. Binds spliced mRNA upstream of exon-exon junctions. In vitro, weakly stimulates translation.. | |
Protein Sequence | MRSEKEGAGGLRAAVAARGPSGREKLSALEVQFHRDSQQQEAETPPTSSSGCGGGAGKPREEKRTALSKVVIRRLPPGLTKEQLEEQLRPLPAHDYFEFFAADLSLYPHLYSRAYINFRNPDDILLFRDRFDGYIFLDSKGLEYPAVVEFAPFQKIAKKKLRKKDAKTGSIEDDPEYKKFLETYCVEEEKTSANPETLLGEMEAKTRELIARRTTPLLEYIKNRKLEKQRIREEKREERRRRELEKKRLREEEKRRRREEERCKKKETDKQKKIAEKEVRIKLLKKPEKGEEPTTEKPKERGEEIDTGGGKQESCAPGAVVKARPMEGSLEEPQETSHSGSDKEHRDVERSQEQESEAQRYHVDDGRRHRAHHEPERLSRRSEDEQRWGKGPGQDRGKKGSQDSGAPGEAMERLGRAQRCDDSPAPRKERLANKDRPALQLYDPGARFRARECGGNRRICKAEGSGTGPEKREEAE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
44 | Phosphorylation | SQQQEAETPPTSSSG CHHHCCCCCCCCCCC | 41.43 | 28165663 | |
47 | Phosphorylation | QEAETPPTSSSGCGG HCCCCCCCCCCCCCC | 42.30 | - | |
68 | Phosphorylation | EEKRTALSKVVIRRL HHHHHHHHHHHHHHC | 22.42 | 22817900 | |
112 | Phosphorylation | SLYPHLYSRAYINFR HHHHHHHHCCCCCCC | 19.45 | 24719451 | |
144 | Phosphorylation | LDSKGLEYPAVVEFA ECCCCCCCCEEEECC | 11.09 | - | |
168 | Phosphorylation | LRKKDAKTGSIEDDP HHHCCCCCCCCCCCH | 37.57 | 24719451 | |
170 | Phosphorylation | KKDAKTGSIEDDPEY HCCCCCCCCCCCHHH | 28.21 | 23312004 | |
179 | Ubiquitination | EDDPEYKKFLETYCV CCCHHHHHHHHHHCC | 55.04 | - | |
183 | Phosphorylation | EYKKFLETYCVEEEK HHHHHHHHHCCHHHC | 25.11 | 29978859 | |
184 | Phosphorylation | YKKFLETYCVEEEKT HHHHHHHHCCHHHCC | 5.78 | 25159151 | |
205 | Ubiquitination | LLGEMEAKTRELIAR HHHHHHHHHHHHHHH | 34.50 | - | |
214 | Phosphorylation | RELIARRTTPLLEYI HHHHHHHHHHHHHHH | 27.49 | 22210691 | |
215 | Phosphorylation | ELIARRTTPLLEYIK HHHHHHHHHHHHHHH | 15.32 | 24719451 | |
220 | Phosphorylation | RTTPLLEYIKNRKLE HHHHHHHHHHCCHHH | 19.71 | 22210691 | |
311 | Acetylation | EIDTGGGKQESCAPG CCCCCCCCCCCCCCC | 54.92 | 26051181 | |
314 | Phosphorylation | TGGGKQESCAPGAVV CCCCCCCCCCCCCEE | 17.06 | 24708550 | |
329 | Phosphorylation | KARPMEGSLEEPQET EEEECCCCCCCCCCC | 21.21 | 21406692 | |
336 | Phosphorylation | SLEEPQETSHSGSDK CCCCCCCCCCCCCCH | 26.88 | 30266825 | |
337 | Phosphorylation | LEEPQETSHSGSDKE CCCCCCCCCCCCCHH | 18.20 | 30266825 | |
339 | Phosphorylation | EPQETSHSGSDKEHR CCCCCCCCCCCHHHH | 39.50 | 30266825 | |
341 | Phosphorylation | QETSHSGSDKEHRDV CCCCCCCCCHHHHHH | 48.82 | 30266825 | |
351 | Phosphorylation | EHRDVERSQEQESEA HHHHHHHHHHHHHHH | 25.27 | 26714015 | |
356 | Phosphorylation | ERSQEQESEAQRYHV HHHHHHHHHHHHCCC | 37.62 | 26714015 | |
379 | Phosphorylation | HHEPERLSRRSEDEQ CCCHHHHHCCCHHHH | 31.69 | 24719451 | |
382 | Phosphorylation | PERLSRRSEDEQRWG HHHHHCCCHHHHHHC | 48.57 | 28102081 | |
401 | Phosphorylation | QDRGKKGSQDSGAPG CCCCCCCCCCCCCCH | 39.43 | 28857561 | |
404 | Phosphorylation | GKKGSQDSGAPGEAM CCCCCCCCCCCHHHH | 29.26 | 28102081 | |
442 | Phosphorylation | DRPALQLYDPGARFR CCCCHHHCCCCHHHE | 13.71 | 27642862 | |
465 | Phosphorylation | RICKAEGSGTGPEKR EEEECCCCCCCHHHH | 25.37 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of REN3A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of REN3A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of REN3A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GSK3B_HUMAN | GSK3B | physical | 15231747 | |
IFM2_HUMAN | IFITM2 | physical | 15231747 | |
RENT2_HUMAN | UPF2 | physical | 14527413 | |
REN3B_HUMAN | UPF3B | physical | 14527413 | |
DCP2_HUMAN | DCP2 | physical | 14527413 | |
XRN1_HUMAN | XRN1 | physical | 14527413 | |
EXOSX_HUMAN | EXOSC10 | physical | 14527413 | |
EXOS2_HUMAN | EXOSC2 | physical | 14527413 | |
EXOS4_HUMAN | EXOSC4 | physical | 14527413 | |
PARN_HUMAN | PARN | physical | 14527413 | |
SMG1_HUMAN | SMG1 | physical | 11544179 | |
RENT1_HUMAN | UPF1 | physical | 11544179 | |
HBB_HUMAN | HBB | physical | 11163187 | |
A4_HUMAN | APP | physical | 21832049 | |
HBB_HUMAN | HBB | physical | 21145460 | |
HD_HUMAN | HTT | physical | 23275563 | |
HBB_HUMAN | HBB | physical | 28514442 | |
CAH1_HUMAN | CA1 | physical | 28514442 | |
HBD_HUMAN | HBD | physical | 28514442 | |
CASC3_HUMAN | CASC3 | physical | 28514442 | |
AGGF1_HUMAN | AGGF1 | physical | 28514442 | |
APOA1_HUMAN | APOA1 | physical | 28514442 | |
A1AT_HUMAN | SERPINA1 | physical | 28514442 | |
RNPS1_HUMAN | RNPS1 | physical | 28514442 | |
LONM_HUMAN | LONP1 | physical | 28514442 | |
ALBU_HUMAN | ALB | physical | 28514442 | |
CK5P3_HUMAN | CDK5RAP3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68, AND MASSSPECTROMETRY. |